One family's history of the rare condition Fabry disease through the generations
- Details
- Category: Shire
In recognition of International Fabry Awareness month, Shire has released the trailer for Our Fabry Family Tree, a short film series featuring a family who were unknowingly affected by Fabry disease for generations before genetic analysis shed light on a diagnosis of the rare condition.
What's the secret to living a full life? A new global survey reveals family comes first
- Details
- Category: Abbott
If you have ever asked yourself, "What makes me feel most fulfilled?" you are not alone. Nearly 2 million people recently answered that question in a new survey by Abbott, the global healthcare company.
Bayer off to a successful start in 2016
- Details
- Category: Bayer
The Bayer Group got off to a successful start in the new fiscal year. "All segments posted gains in their operating performance," said CEO Dr. Marijn Dekkers when he presented the interim report for the first quarter on Tuesday. At Pharmaceuticals, Bayer again benefited from the very good development of its recently launched products.
Merck brings international start-up-companies to Darmstadt and Nairobi
- Details
- Category: Merck Group
Merck, a leading science and technology company, has announced the participants for its Accelerator Programs in Darmstadt and Nairobi. Almost 200 highly competitive applications from 47 countries were submitted for consideration.
2016 Otto Bayer Award goes to Professor Dr. Dirk Trauner
- Details
- Category: Bayer
The award-winner of the 2016 Otto Bayer Award has been named: the Board of Trustees of the Bayer Science & Education Foundation and the Scientific Committee for this award have presented Professor Dr. Dirk Trauner with the EUR 75,000 prize, one of Germany's most prestigious scientific accolades.
AstraZeneca launches integrated genomics approach to transform drug discovery and development
- Details
- Category: AstraZeneca
AstraZeneca and its global biologics research and development arm, MedImmune, today announced an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline.
Novartis delivered solid Q1 despite Gleevec loss of exclusivity
- Details
- Category: Novartis
Novartis laid out five priorities for 2016: deliver strong financial results; strengthen innovation; improve Alcon performance; capture cross-divisional synergies; and build a higher-performing organization. Net sales were USD 11.6 billion (-3%, +1% cc) in the first quarter, as volume growth of 7 percentage points more than offset the negative impact of generic competition (-4 percentage points) and pricing (-2 percentage points).
More Pharma News ...
- Roche reports solid sales growth in the first quarter of 2016
- FDA grants priority review for Roche's cancer immunotherapy atezolizumab in specific type of lung cancer
- New analysis shows only minority of COPD patients may benefit from inhaled corticosteroids
- AstraZeneca and Eli Lilly and Company announce continuation of pivotal clinical trial for people with early Alzheimer's disease
- Pfizer announces termination of proposed combination with Allergan
- Johnson & Johnson announces launch of new global public health strategy at opening of new operations in Africa
- Saxenda® demonstrated significant improvements in cardiometabolic risk factors over three years compared with placebo